SEC 13F Intelligence

Managers / Q1 2024 · view latest →

Sonic GP LLC

CIK 0001964290 · 400 HOBRON LANE, SUITE 3709, HONOLULU, HI, 96815 · 8086493381

Reported Value
$76M
Q1 2024
Positions
15
Filings on Record
9
2019–present window
Filed
May 15, 2024
original filing

Summary

Sonic GP LLC reported $76M in U.S.-listed holdings across 15 positions for Q1 2024.

The portfolio is heavily concentrated: FENC alone accounts for 35.3% of reported value.

Compared with Q4 2023, the fund opened 1 new position and exited 2.

Portfolio Metrics

Turnover
+8.5%
vs prior filed quarter
Top-10 Concentration
+96.3%
share of reported value
Largest Position
+35.3%
Fennec Pharmaceuticals
New / Exited
1 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $133MQ4 ’22Q1 ’23: $131MQ2 ’23: $150MQ2 ’23Q3 ’23: $103MQ4 ’23: $87MQ4 ’23Q1 ’24: $76MQ2 ’24: $48MQ2 ’24Q3 ’24: $44MQ4 ’24: $45MQ4 ’24filingsflow.com

Portfolio Composition

By security type
Common Stock: 90.8%Other: 8.7%Equity WRT: 0.5%
  • Common Stock · 90.8% · $69M
  • Other · 8.7% · $7M
  • Equity WRT · 0.5% · $383,593

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MURAL ONCOLOGY PUB LTD CONEW+167.0K167.0K+$816,552$816,552
SPIRIT AIRLS INCSOLD OUT700.0K0$11M$0
ADVERUM BIOTECHNOLOGIES INCSOLD OUT2.00M0$2M$0
PRKSUNITED PARKS & RESORTS INCTRIMMED45.8K54.2K$2M$3M
RGNXREGENXBIO INCADDED+100.0K543.1K+$3M$11M
BHFBRIGHTHOUSE FINL INCTRIMMED20.0K100.0K$1M$5M
CEDAR FAIR L PTRIMMED20.0K120.0K$544,000$5M
CCITIGROUP INCHELD+0100.7K+$1M$6M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

14 positions
#IssuerClass% PortfolioValueShares
1FENCFENNEC PHARMACEUTICALS INChistory →COM35.34%$27M2.41M
2RGNXREGENXBIO INChistory →COM15.10%$11M543.1K
3UALUNITED AIRLS HLDGS INChistory →COM10.86%$8M171.8K
4CCITIGROUP INChistory →COM NEW8.41%$6M100.7K
5BHFBRIGHTHOUSE FINL INChistory →COM6.80%$5M100.0K
6CEDAR FAIR L PDEPOSITRY UNIT6.64%$5M120.0K
7ASTLALGOMA STL GROUP INCCOM · *W EXP 10/19/2024.99%$4M680.0K
8PRKSUNITED PARKS & RESORTS INChistory →COM4.02%$3M54.2K
9VIRTVIRTU FINL INChistory →CL A2.71%$2M100.0K
10TROXTRONOX HOLDINGS PLChistory →SHS1.44%$1M63.1K
11AUIDAUTHID INChistory →COM1.26%$953,750125.0K
12MURAL ONCOLOGY PUB LTD COORD SHS1.08%$816,552167.0K
13REE AUTOMOTIVE LTDSHS CL A NEW1.01%$763,130130.7K
14QUREUNIQURE NVSHS0.34%$260,00050.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2024$45M15Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$44M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$48M15Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$76M15May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$87M16Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$103M23Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$150M24Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$131M25May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$133M25Feb 14, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.